P-gp inhibitor 1

CAS No. 2050747-49-2

P-gp inhibitor 1 ( —— )

Catalog No. M26354 CAS No. 2050747-49-2

P-gp inhibitor 1 inhibits reversing P-glycoprotein-mediated multidrug resistance with an EC50 of 57.9 nM (K562/A02 cells).

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 Get Quote
10MG 192 Get Quote
25MG 385 Get Quote
50MG 575 Get Quote
100MG 801 Get Quote
500MG 1647 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    P-gp inhibitor 1
  • Note
    Research use only, not for human use.
  • Brief Description
    P-gp inhibitor 1 inhibits reversing P-glycoprotein-mediated multidrug resistance with an EC50 of 57.9 nM (K562/A02 cells).
  • Description
    P-gp inhibitor 1 inhibits reversing P-glycoprotein-mediated multidrug resistance with an EC50 of 57.9 nM (K562/A02 cells).(In Vitro):In K562/A02 MDR cells, P-gp inhibitor 1 (0.1, 1, 5 μM, 1 h) boosts the potency of other MDR-related cytotoxic agents with different structures, increases the accumulation of DOX, blocks Pgp-mediated Rh123 efflux, and suppresses P-gp ATPase activity.
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Histamine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2050747-49-2
  • Formula Weight
    517.6
  • Molecular Formula
    C32H31N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    COc1cc2CCN(CCc3ccc(Nc4nc(nc5ccccc45)-c4ccncc4)cc3)Cc2cc1OC
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Miura M, Uno T. Clinical pharmacokinetics of fexofenadine enantiomers. Expert Opin Drug Metab Toxicol. 2010 Jan;6(1):69-74.
molnova catalog
related products
  • (R)-P7C3-Ome

    P7C3 is a drug related to latrepirdine (dimebon), which has neuroprotective and proneurogenic effects, and may be potentially useful for the treatment of Alzheimer's disease and similar neurodegenerative disorders.

  • Enprofylline

    Enprofylline, a bronchodilator, acts primarily as a competitive nonselective phosphodiesterase inhibitor.

  • Aka Lumine

    AkaLumine is a luciferin analogue.